Compared to normal counterparts, both the MDH1 and the MDH2 enzymes display elevated levels in NSCLC, while only high expression of MDH1 is related to the poor prognosis of NSCLC patients. This evidence concerns the gene MDH1 and non-small cell lung carcinoma.